ATC code M05B
Drugs affecting bone structure and mineralization
23 drugs in ATC group M05B “Drugs affecting bone structure and mineralization” in UK.
Aclasta 5 mg solution for infusionZoledronic acid · Novartis Europharm Ltd.- ADROVANCE 70 mg/2800 IU tabletsMerck Sharp & Dohme Ltd.
- ADROVANCE 70 mg/5600 IU tabletsMerck Sharp & Dohme Ltd.
- Bondenza 150 mg film-coated tabletsIbandronic acid · Roche Registration Ltd.
- Bondenza 3 mg solution for injectionIbandronic acid · Roche Registration Ltd.
- Bonviva 150 mg film-coated tabletsIbandronic acid · Roche Registration Ltd.
- Bonviva 3 mg solution for injectionIbandronic acid · Roche Registration Ltd.
- FOSAVANCE 70 mg/2800 IU tabletsMerck Sharp & Dohme Ltd.
- FOSAVANCE 70 mg/5600 IU tabletsMerck Sharp & Dohme Ltd.
- Iasibon 1 mg concentrate for solution for infusionIbandronic acid · Pharmathen S.A.
- Iasibon 2 mg concentrate for solution for infusionIbandronic acid · Pharmathen S.A.
- Iasibon 50 mg Film Coated TabletsIbandronic acid · Pharmathen S.A.
- Iasibon 6 mg Concentrate for solution for infusionIbandronic acid · Pharmathen S.A.
- Ibandronic Acid Teva 150 mg film-coated tabletsIbandronic acid · Teva Pharma B.V.
- Ibandronic Acid Teva 50 mg film-coated tabletsIbandronic acid · Teva Pharma B.V.
- Opgenra 3.3 mg powders for suspension for implantationEptotermin alfa · Howmedica International S. de R. L.
- Osigraft 3.3 mg powder for suspension for implantationEptotermin alfa · Howmedica International S. de R. L.
- Prolia 60 mg solution for injectionAmgen Europe B.V.
- Prolia 60 mg solution for injection in a pre-filled syringeAmgen Europe B.V.
- VANTAVO 70 mg/2800 IU tabletsMerck Sharp & Dohme Ltd.
- VANTAVO 70 mg/5600 IU tabletsMerck Sharp & Dohme Ltd.
- Zometa 4 mg powder and solvent for solution for infusionZoledronic acid · Novartis Europharm Ltd.
- Zometa 4 mg/5 ml concentrate for solution for infusionZoledronic acid · Novartis Europharm Ltd.
Advertisement